Valeant to buy Obagi Medical Products for $19.75 per share; Merz tops bid, offers $22 apiece; Valeant comes back offering $24
- OTC, Consumer
- Topical Delivery
- Full Acquisition
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.